Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2238531 | chr16:89856217 | C/G | 0.000159 | 177 | 25.87 | 20.37 | 36.37 | KM Plot |
PCPG | rs2238532 | chr16:89863672 | T/C | 0.000186 | 173 | 25.87 | 21.5 | 36.37 | KM Plot |
PCPG | rs2239356 | chr16:89827239 | T/C | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs2239357 | chr16:89827251 | G/A | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs2239358 | chr16:89827330 | C/G | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs2240773 | chr17:74710783 | C/A | 0.000139 | 177 | 26.27 | 14.35 | 13.5 | KM Plot |
PCPG | rs2241037 | chr16:90101827 | C/T | 7.58E-9 | 177 | 25.87 | 20.28 | 6.62 | KM Plot |
PCPG | rs2248420 | chr21:34605778 | C/T | 0.000273 | 173 | 23.43 | 31.97 | 25.17 | KM Plot |
PCPG | rs2254780 | chr2:136435526 | C/T | 0.00021 | 178 | 25.53 | 25.67 | 14.5 | KM Plot |
PCPG | rs2257294 | chr13:114157724 | G/A | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2257298 | chr13:114157569 | G/T | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2258299 | chr13:114167971 | G/A | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2258368 | chr13:114167414 | C/T | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2258373 | chr13:114167313 | G/A | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2258375 | chr13:114167187 | A/G | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |